À. Ainsi and . Partir, une dose correspondant à 50 mg d'harpagoside, 25 mg soit la moitié sera disponible pour la résorption intestinale

. Ng, 8 à 200 mg. La demie-vie plasmatique est courte (entre 3,7 et 6,4 heures) et les auteurs signalent qu'un taux mesurable d'harpagoside sanguin n'est atteint que

L. Toxicité, harpagophytum procumbens est jugée très faible. À ce jour, il n'y a pas eu d'effets secondaires rapportés suite à son utilisation. Une étude toxicologique sur les rats a conclu qu

C. Tenu, état des connaissances actuelles sur ce sujet, la supplémentation en cuivre dans les compléments alimentaires est très souvent recommandée et a lieu à très petite dose très loin des doses toxiques (0,5 mg, ou des doses létales

. Le-cuivre, agirait en enrayant le processus inflammatoire (anti-IL1), et en augmentant la quantité d'antioxydants par son action

B. 1. Autefage, Pathophysiologie et diagnostic de l'ostéoarthroseLes Affections Articulaire, pp.199-201, 1995.

I. M. Martinac-b and H. C. , Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage, Ostearthritis Cartilage, vol.1, pp.613-622, 2003.

C. J. Laverty-s and R. F. , Arthrose : physio-pathologie et aspects actuels des traitements, pp.185-193, 1996.

P. J. Symons-j and R. R. , Cytokines: inflammatory mediators of joint disease, Equine Veterinary Journal, vol.24, pp.78-80, 1992.

K. B. and J. B. Schunke-m, Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice, Ostearthritis Cartilage, vol.10, pp.119-126, 2001.

F. C. Kratz-a, Nutraceuticals: challenges and opportunities for the new millennium that affect consumers and healthcare professionals who use and recommend nutraceuticals, pp.6-10, 1999.

P. C. Laverty-s, La glucosamine dans le traitement de l'ostéoarthrose. Revue bibliographique, pp.31-36, 2000.

F. C. Kratz-a, Nutraceuticals: challenges and opportunities for the new millennium that affect consumers and healthcare professionals who use and recommend nutraceuticals, pp.6-10, 1999.

B. B. Goring-r, Degenerative joint disease, Disease Mechanisms in Small Animal Surgery, pp.727-736, 1993.

I. C. Mc, General pathobiology of the joint and response to injury. Joint Disease in the Horse, p.70, 1996.

D. Los, R. G. Koda-r, and L. E. , Glucosamine and chondroïtine sulfates in the treatment of osteoarthritis: a survey, Prog. Drug. Res, vol.55, pp.81-103, 2000.

C. S. Billingham-m and . Caterson-b, Changes in proteoglycane turnover in experimental canine osteoarthritic cartilage, Matrix, vol.12, p.137, 1992.

D. Los, R. G. Koda-r, and L. E. , Glucosamine and chondroitin sulfates in the treatment of osteoarthritis : a survey, Prog. Drug. Res, vol.55, pp.81-103, 2000.

E. N. and D. J. White-n, Evidence of the oral absorption of chondroitin sulfate as determined by total disaccharide content after oral and IV administration to horses, pp.43-44, 2001.

D. V. Guerrero-r, Effects of oral intramuscular use of chondroïtine sulfate in induced equine aseptic arthritis, J. Equine Vet. Sci, vol.18, pp.548-555, 1998.

B. J. and C. H. Neuzil-e, Biochemical basis of the pharmacological action of chondroitin sulfates on the osteoarticular system, Arthritis and Rheumatism, vol.31, pp.58-68, 2001.

H. Ye, D. Ma, C. Jm, P. N. , M. P. et al., Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes, pp.1668-78, 2006.

H. Ye, L. Ah, J. Jm, Z. De-groote-dd, G. Sx et al., Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes, pp.31-40, 1998.

B. F. Maheu-e, W. A. , and C. H. Lopez-a, Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial, pp.76-84, 2004.

P. Se, C. Af, and R. L. Mckee, A study of the absorption Methylsulfonylmethane in horses, Proc 17e Physiol Nutr Soc Equine, pp.141-142

H. K. , N. Pe, S. , G. R. , F. I. et al., Toxicity of methylsulfonylmethane in rats

H. T. Kumamoto-s, U. S. , and Y. Y. , Suppressive effect of methylsulfonylmethane (MSM) on Type-II collagen induced arthritis in SBA/1J mice, Jpn Pharmacol Ther, vol.32, pp.421-428, 2004.

A. D. Phd, ;. Healey-r-m, M. Bs, O. Y. Md, and P. , Assessment of Methylsulfonylmethane (MSM) on the developement of osteoarthritis (OA): An animal study FASEB J, pp.109-110, 2008.

K. Ls, A. Lj, H. P. , B. N. , and W. Rf, Efficacy of methylsulfonyl-methane (MSM) in osteoarthritis pain of the knee : a pilot clinical atrial, Osteoarthritis and Cartilage, vol.14, pp.286-94, 2006.

R. M. Lawrence-md and P. D. , Assistant Clinical Professor UCLA School of Medicine Professeur adjoint de clinique UCLA School of Medicine Methylsulfonylmethane (MSM) a double-blind study of its use of degenerative arthritis, Int J Anti-Aging Med, vol.1, p.50, 1998.

W. M. Anton and R. , Plantes thérapeutiques, pratique officinale, science et thérapeutique, pp.248-50, 2002.

J. Raynaud, Prescription et conseil en phytothérapie, pp.196-204, 2005.

G. Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle (Urtica dioica L.), J-Ethnopharmacol, vol.90, pp.2-3, 2004.

T. G. Robinson-m, Urinary and fecal excretion and absorption of large supplement of selenium: superiority of selenate over selenite, J. Clin. Nut, vol.44, pp.659-663, 1986.

L. P. Salat-o and N. J. , Un point sur le sélénium, Bulletin des GTV, pp.35-47, 1998.

D. F. Belleville-f, Sélénium : rôle physiologique et intérêt en pathologie humaine, Path. Biol, issue.8, pp.36-1017, 1988.

L. P. Salat-o and N. J. , Un point sur le sélénium, Bulletin des GTV, vol.5, pp.35-47, 1998.

H. C. Fitzpatrick-d, . D. Trick-k, and M. R. L-'abbe, Dietary iodine and selenium interact to affect thyroid hormone metabolism of rats, Journal of Nutrition, issue.6, pp.127-1214, 1997.

D. F. Belleville-f, Sélénium : rôle physiologique et intérêt en pathologie humaine, Path. Biol, issue.8, pp.36-1017, 1988.

Y. K. , A. S. Sato-h, and . Aono-h, -Circadian rhythms of seven heavy metals in plasma, erythrocytes and urine in men: observation in metal workers, Industrial Health, vol.38, pp.205-217, 2000.

R. Mazieress, B. , and D. M. , Evaluation du cuivre dans le traitement symptomatique de la gonarthrose, Réflexions Rhumatologiques, vol.28, pp.3-6, 2000.

N. K. and C. J. Orth-w, The role of glucosamine and chondroitin sulphate in treatment for and prevention of osteoarthritis in animals, J. Am. Vet. Med. Assoc, vol.226, pp.1079-1088, 2005.

N. K. Orth-m, C. P. , C. P. , and C. J. , Effects of glucosamine and chondroitine sulphate on mediators of osteoarthritis in cultured equine chondrocytes stimulated by use of recombinant equine interleukin-1beta, Am. J.Vet.Res, vol.66, pp.1861-1869, 2005.

M. A. , L. G. , and P. Jp, Effect of unsaponifiable extracts of avocado and soybean (Piascledine) on the collagenolytic action of cultures of human rheumatoid synoviocytes and rabbit articular chondrocytes treated with interleukin-1, Rev. Rhum. Mal. Osteoartic, vol.58, issue.4, pp.241-246, 1991.

V. Wyk and B. , Medicinal plants of the world, pp.34-35, 2004.
DOI : 10.1079/9781786393258.0000

W. T. and L. Np, Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.). Phytother Res, pp.1165-72, 2003.

L. , M. , F. J. Mortier, F. , and V. A. , Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens, Planta Medica, vol.58, pp.117-123, 1992.

S. E. Andersen-m-l, D. Seabra-m-v, and T. S. Silva-a-b, Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund???s adjuvant-induced arthritis in rats, Journal of Ethnopharmacology, vol.91, issue.2-3, pp.2-3, 2004.
DOI : 10.1016/j.jep.2004.01.003

S. Hansen-c and S. M. , Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro, Arzneimittel-Forschung, vol.54, issue.4, pp.213-233, 2004.

J. T. Muller-r-d, O. A. , Z. H. , and K. B. , Interleukin-10 modulates pro-apoptotic effects of TNF-alpha in human articular chondrocytes in vitro, Cytokine, vol.40, issue.3, pp.226-260, 2007.

S. Hansen-c, S. M. , and S. A. , Effects of the antirheumatic remedy hox alpha--a new stinging nettle leaf extract--on matrix Metalloproteinases in human chondrocytes in vitro, Histol Histopathol, vol.17, issue.2, pp.477-485, 2002.

D. H. Monto-f, Antinociceptive and antiinflammtory properties of the hydroalcoholic extract of stem from Equisetum arvense L. in mice, Pharmacol rem, pp.239-282, 2004.

K. K. Monograph, Boswellia serrata, common name : Frankincense, Alternative Medicine Review, pp.22-24, 1998.

V. D. Chappuis-p, A. J. Bost-m, and A. M. Roussel-a, Selenium, glutathione peroxidase, peroxides and platelet functions ; Annales de biologie clinique, pp.54-181, 1996.

L. , M. , F. J. Mortier, F. , and V. A. , Antiinflammatory and analgesic effects of an aqueous extract of Harpagophytum procumbens, Planta Medica, vol.58, pp.117-123, 1992.

L. D. and M. J. Schrodter-a, Investigations on the pharmacokinetic properties in humans of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo, Clinical Pharmacology and Therapeutics, vol.69, issue.5, pp.356-364, 2001.